Your browser doesn't support javascript.
SARS-CoV-2 positivity in offspring and timing of mother-to-child transmission: living systematic review and meta-analysis.
Allotey, John; Chatterjee, Shaunak; Kew, Tania; Gaetano, Andrea; Stallings, Elena; Fernández-García, Silvia; Yap, Magnus; Sheikh, Jameela; Lawson, Heidi; Coomar, Dyuti; Dixit, Anushka; Zhou, Dengyi; Balaji, Rishab; Littmoden, Megan; King, Yasmin; Debenham, Luke; Llavall, Anna Clavé; Ansari, Kehkashan; Sandhu, Gurimaan; Banjoko, Adeolu; Walker, Kate; O'Donoghue, Keelin; van Wely, Madelon; van Leeuwen, Elizabeth; Kostova, Elena; Kunst, Heinke; Khalil, Asma; Brizuela, Vanessa; Broutet, Nathalie; Kara, Edna; Kim, Caron Rahn; Thorson, Anna; Oladapo, Olufemi T; Zamora, Javier; Bonet, Mercedes; Mofenson, Lynne; Thangaratinam, Shakila.
  • Allotey J; WHO Collaborating Centre for Global Women's Health, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
  • Chatterjee S; Birmingham Medical School, University of Birmingham, Birmingham, UK.
  • Kew T; Birmingham Medical School, University of Birmingham, Birmingham, UK.
  • Gaetano A; Clinical Biostatistics Unit, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.
  • Stallings E; CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Fernández-García S; Clinical Biostatistics Unit, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.
  • Yap M; CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Sheikh J; Clinical Biostatistics Unit, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.
  • Lawson H; Birmingham Medical School, University of Birmingham, Birmingham, UK.
  • Coomar D; Birmingham Medical School, University of Birmingham, Birmingham, UK.
  • Dixit A; Birmingham Medical School, University of Birmingham, Birmingham, UK.
  • Zhou D; WHO Collaborating Centre for Global Women's Health, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
  • Balaji R; Birmingham Medical School, University of Birmingham, Birmingham, UK.
  • Littmoden M; Birmingham Medical School, University of Birmingham, Birmingham, UK.
  • King Y; Birmingham Medical School, University of Birmingham, Birmingham, UK.
  • Debenham L; Birmingham Medical School, University of Birmingham, Birmingham, UK.
  • Llavall AC; University of Nottingham, Nottingham, UK.
  • Ansari K; Birmingham Medical School, University of Birmingham, Birmingham, UK.
  • Sandhu G; Birmingham Medical School, University of Birmingham, Birmingham, UK.
  • Banjoko A; WHO Collaborating Centre for Global Women's Health, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
  • Walker K; Birmingham Medical School, University of Birmingham, Birmingham, UK.
  • O'Donoghue K; Birmingham Medical School, University of Birmingham, Birmingham, UK.
  • van Wely M; University of Nottingham, Nottingham, UK.
  • van Leeuwen E; University College Cork, Cork, Ireland.
  • Kostova E; Netherlands Satellite of the Cochrane Gynaecology and Fertility Group, Amsterdam University Medical Centre, Amsterdam, Netherlands.
  • Kunst H; Department of Obstetrics and Gynaecology, Amsterdam University Medical Centre, Amsterdam, Netherlands.
  • Khalil A; Netherlands Satellite of the Cochrane Gynaecology and Fertility Group, Amsterdam University Medical Centre, Amsterdam, Netherlands.
  • Brizuela V; Blizard Institute, Queen Mary University of London, London, UK.
  • Broutet N; Barts Health NHS Trust, London, UK.
  • Kara E; St George's University London, London, UK.
  • Kim CR; UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
  • Thorson A; UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
  • Oladapo OT; UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
  • Zamora J; UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
  • Bonet M; UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
  • Mofenson L; UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
  • Thangaratinam S; WHO Collaborating Centre for Global Women's Health, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
BMJ ; 376: e067696, 2022 03 16.
Article in English | MEDLINE | ID: covidwho-1745760
ABSTRACT

OBJECTIVES:

To assess the rates of SARS-CoV-2 positivity in babies born to mothers with SARS-CoV-2 infection, the timing of mother-to-child transmission and perinatal outcomes, and factors associated with SARS-CoV-2 status in offspring.

DESIGN:

Living systematic review and meta-analysis. DATA SOURCES Major databases between 1 December 2019 and 3 August 2021. STUDY SELECTION Cohort studies of pregnant and recently pregnant women (including after abortion or miscarriage) who sought hospital care for any reason and had a diagnosis of SARS-CoV-2 infection, and also provided data on offspring SARS-CoV-2 status and risk factors for positivity. Case series and case reports were also included to assess the timing and likelihood of mother-to-child transmission in SARS-CoV-2 positive babies. DATA EXTRACTION Two reviewers independently extracted data and assessed study quality. A random effects model was used to synthesise data for rates, with associations reported using odds ratios and 95% confidence intervals. Narrative syntheses were performed when meta-analysis was inappropriate. The World Health Organization classification was used to categorise the timing of mother-to-child transmission (in utero, intrapartum, early postnatal).

RESULTS:

472 studies (206 cohort studies, 266 case series and case reports; 28 952 mothers, 18 237 babies) were included. Overall, 1.8% (95% confidence interval 1.2% to 2.5%; 140 studies) of the 14 271 babies born to mothers with SARS-CoV-2 infection tested positive for the virus with reverse transcriptase polymerase chain reaction (RT-PCR). Of the 592 SARS-CoV-2 positive babies with data on the timing of exposure and type and timing of tests, 14 had confirmed mother-to-child transmission seven in utero (448 assessed), two intrapartum (18 assessed), and five during the early postnatal period (70 assessed). Of the 800 SARS-CoV-2 positive babies with outcome data, 20 were stillbirths, 23 were neonatal deaths, and eight were early pregnancy losses; 749 babies were alive at the end of follow-up. Severe maternal covid-19 (odds ratio 2.4, 95% confidence interval 1.3 to 4.4), maternal death (14.1, 4.1 to 48.0), maternal admission to an intensive care unit (3.5, 1.7 to 6.9), and maternal postnatal infection (5.0, 1.2 to 20.1) were associated with SARS-CoV-2 positivity in offspring. Positivity rates using RT-PCR varied between regions, ranging from 0.1% (95% confidence interval 0.0% to 0.3%) in studies from North America to 5.7% (3.2% to 8.7%) in studies from Latin America and the Caribbean.

CONCLUSION:

SARS-CoV-2 positivity rates were found to be low in babies born to mothers with SARS-CoV-2 infection. Evidence suggests confirmed vertical transmission of SARS-CoV-2, although this is likely to be rare. Severity of maternal covid-19 appears to be associated with SARS-CoV-2 positivity in offspring. SYSTEMATIC REVIEW REGISTRATION PROSPERO CRD42020178076. READERS' NOTE This article is a living systematic review that will be updated to reflect emerging evidence. Updates may occur for up to two years from the date of original publication.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pregnancy Complications, Infectious / Pregnancy Outcome / Infectious Disease Transmission, Vertical / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study / Randomized controlled trials / Reviews / Systematic review/Meta Analysis Limits: Female / Humans / Infant, Newborn / Pregnancy Language: English Journal: BMJ Journal subject: Medicine Year: 2022 Document Type: Article Affiliation country: Bmj-2021-067696

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pregnancy Complications, Infectious / Pregnancy Outcome / Infectious Disease Transmission, Vertical / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study / Randomized controlled trials / Reviews / Systematic review/Meta Analysis Limits: Female / Humans / Infant, Newborn / Pregnancy Language: English Journal: BMJ Journal subject: Medicine Year: 2022 Document Type: Article Affiliation country: Bmj-2021-067696